Cargando…
Two-stage penalized regression screening to detect biomarker-treatment interactions in randomized clinical trials
High-dimensional biomarkers such as genomics are increasingly being measured in randomized clinical trials. Consequently, there is a growing interest in developing methods that improve the power to detect biomarker–treatment interactions. We adapt recently proposed two-stage interaction detecting pr...
Autores principales: | Wang, Jixiong, Patel, Ashish, Wason, James M.S., Newcombe, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613856/ https://www.ncbi.nlm.nih.gov/pubmed/33448327 http://dx.doi.org/10.1111/biom.13424 |
Ejemplares similares
-
Point estimation following a two-stage group sequential trial
por: Grayling, Michael J, et al.
Publicado: (2022) -
Discovery of protein–DNA interactions by penalized multivariate regression
por: Zamdborg, Leonid, et al.
Publicado: (2009) -
Application of penalized linear regression methods to the selection of environmental enteropathy biomarkers
por: Lu, Miao, et al.
Publicado: (2017) -
Comparison of multimarker logistic regression models, with application to a genomewide scan of schizophrenia
por: Wason, James MS, et al.
Publicado: (2010) -
Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)